Skip to Content

Notice

Science Board to the Food and Drug Administration; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

Name of Committee: Science Board to the Food and Drug Administration.

General Function of the Committee: To provide advice and recommendations to the agency on FDA's regulatory issues.

Date and Time: The meeting will be held on November 17, 2000, 8:30 a.m. to 5 p.m.

Location: Food and Drug Administration, CDER Advisory Committee Meeting Room, 5630 Fishers Lane, Rockville, MD 20857.

Contact Person: Susan Mackie Bond, Office of Science Coordination and Communication (HF-33), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-6687, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12603. Please call the Information Line for up-to-date information on this meeting.

Agenda: The board will meet to hear and to discuss the following issues: (1) Emerging science issues at FDA, (2) strategies for maintaining quality of science at FDA, and (3) programmatic peer review.

Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by November 7, 2000. Oral presentations from the public will be scheduled between approximately 1 p.m. to 2 p.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before November 7, 2000, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).

Start Signature

Dated: October 18, 2000.

Linda S. Suydam,

Senior Associate Commissioner.

End Signature End Preamble

[FR Doc. 00-27456 Filed 10-25-00; 8:45 am]

BILLING CODE 4160-01-F